As iron continues to build up in the body, complications happen more often
of deaths in thalassemia major patients are due to cardiac disease and complications.
Causes of death in thalassemia patients until the late 1990s
Monitor for renal/hepatic toxicity
Regular monitoring of both renal and hepatic toxicity can help optimize chelation and ensure patients are on an appropriate chelator.
The only way to know if your patients’ iron chelator is working is to have their iron levels checked regularly
Iron chelation needs to be adjusted regularly or even switched depending on iron level, weight, and tolerance to side effects
|Thalassemia treatment guidelines support regular monitoring of serum ferritin, and cardiac and liver MRI T2*.|
|Serum ferritin||<1,000 ng/mL||Monthly|
|Cardiac MRI T2*||20 ms or higher||Annually (Or every 6 months for those patients with T2* <10 ms)|
|Liver iron concentration (LIC)||<3,000 µg/g dry weight||Annually|
Lowering serum ferritin and liver iron concentration are not enough.